Judge Pratters death may have an impact on the ongoing Ozempic Lawsuits, which allege severe gastrointestinal side effects from glucagon-like peptide-1 (GLP-1) receptor agonists used in diabetes and weight loss treatments
[13] [15] Additionally, GLP-1 medications slow gastric emptying, prolonging the time food remains in the stomach and contributing to increased satiety
This is where the GLP-1 revolution has introduced promising solutions like compounded semaglutide for resetting these metabolic pathways
Due to light absorption, exposure to oxygen tension, and high metabolic and energy demands, the retina is an environment highly susceptible to the formation of ROS, including oxidants and free radicals, which damage cellular proteins and lipid membranes 1,2,3,4
[5] Moon HS, et al
The inability to sustain weight loss may be due to PYY 3-36 -induced Y2-R down-regulation and tolerance (i.e., tachyphylaxis) and/or activation of compensatory mechanisms in response to reduced food intake